Skip to main content
SpringerLink
Log in

Design and Development of Gliclazide Mucoadhesive Microcapsules: In Vitro and In Vivo Evaluation

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

In this study an attempt was made to prepare mucoadhesive microcapsules of gliclazide using various mucoadhesive polymers designed for oral controlled release. Gliclazide microcapsules were prepared using sodium alginate and mucoadhesive polymer such as sodium carboxymethyl cellulose (sodium CMC), carbopol 934P or hydroxy propylmethyl cellulose (HPMC) by orifice-ionic gelation method. The microcapsules were evaluated for surface morphology and particle shape by scanning electron microscope. Microcapsules were also evaluated for their microencapsulation efficiency, in vitro wash-off mucoadhesion test, in vitro drug release and in vivo study. The microcapsules were discrete, spherical and free flowing. The microencapsulation efficiency was in the range of 65–80% and microcapsules exhibited good mucoadhesive property in the in vitro wash off test. The percentage of microcapsules adhering to tissue at pH 7.4 after 6 h varied from 12–32%, whereas the percentage of microcapsules adhering to tissue at pH 1.2 after 6 h varied from 35–68%. The drug release was also found to be slow and extended for more than 16 h. In vivo testing of the mucoadhesive microcapsules in diabetic albino rats demonstrated significant antidiabetic effect of gliclazide. The hypoglycemic effect obtained by mucoadhesive microcapsules was for more than 16 h whereas gliclazide produced an antidiabetic effect for only 10 h suggesting that mucoadhesive microcapsules are a valuable system for the long term delivery of gliclazide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. T. Kristmundsottir, and K. Ingvarsdotir. Ibuprofen microcapsules: The effect of production variables on microcapsule properties. Drug Dev Ind Pharm. 20:769–778 (1990).

    Article  Google Scholar 

  2. N. Bolourtchian, Karimi, and R. Aboofazeli. Preparation and characterization of ibuprofen microspheres. J Microencapsul. 22:529–538 (2005).

    Article  CAS  Google Scholar 

  3. J. A. Bakan. Microencapsulation. The Theory and practice of Industrial pharmacy, In L. Lachman, and H. A. Liberman (eds.), 2nd ed., Varghese, Mumbai, India, 1991, pp. 412–428.

    Google Scholar 

  4. J. K. Vasir, K. Tambwekar, and S. Garg. Bioadhesive microspheres as a controlled drug delivery system. Int J Pharm. 255:13–32 (2003).

    Article  CAS  Google Scholar 

  5. K. P. R. Chowdary, and Y. S. Rao. Mucoadhesive microspheres for oral controlled drug delivery. Biol Pharm Bull. 27:717–1724 (2004).

    Article  Google Scholar 

  6. S. A. S. Tabassi, and N. Razavi. Preparation and characterization of albumin microspheres encapsulated with propranolol HCl. DARU. 11:137–141 (2003).

    CAS  Google Scholar 

  7. S. Haznedar, and B. Dortunc. Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide. Int J Pharm. 269:131–140 (2004).

    Article  CAS  Google Scholar 

  8. K. P. R. Chowdary, and Y. S. Rao. Preparation and evaluation of mucoadhesive microcapsules of indomethacin. Saudi Pharm J. 11:97–103 (2003).

    CAS  Google Scholar 

  9. M. Bogataj, A. Mrhar, and L. Korosec. Influence of physiochemical and biological parameters on drug release from microspheres adhered on vesical and intestinal mucosa. Int J Pharm. 177:211–220 (1999).

    Article  CAS  Google Scholar 

  10. D. E. Chickering, and E. Mathiowitz. Bioadhesive microspheres I.A novel electrobalance-based method to study adhesive interactions between individual microspheres and intestinal mucosa. J Control Release. 34:251–261 (1995).

    Article  CAS  Google Scholar 

  11. K. D Tripathi. Essentials of Medical Pharmacology, 4th ed., Jaypee Brothers, Medical Publishers, New Delhi, India, 1999, pp. 276–278.

    Google Scholar 

  12. G. Scherathaner et al. Guide study: double - blind comparison of once - daily gliclazide MR and glimepiride in type 2 diabetic patients. Eur J Clin Invest. 34:535–542 (2004).

    Article  Google Scholar 

  13. S. K. Wangnoo. Treatment of type 2 diabetes with gliclazide modified release 60 mg in the primary care setting of India. Int J Diab Dev Countries. 25:50–54 (2005).

    Article  Google Scholar 

  14. J. F. Yong, G. L. Wei, R. Lu, C. X. Liu, B. Z. Zheng, and P. Feng. Bioavailability of gliclazide sustained release tablet in healthy volunteers. Asian J Pharmcodyn Pharmucokin. 2:153–160 (2006).

    Google Scholar 

  15. E. A. Arno, P. Anand, K. Bhaskar, S. Ramchandran, M. Saravanan, and R. Vinod. Eudragit NE 30D based metformin/gliclazide extended release tablets: formulation, characterisation and in vitro release studies. Chem Pharm Bull. 5011:1495–1498 (2002).

    Article  Google Scholar 

  16. K. P. R. Chowdary, and Y. S. Rao. Design and In vitro and in vivo evaluation of Mucoadhesive microcapsules of glipizide for oral controlled release A technical note. AAPS Pharm Sci Tech. 4:1–6 (2003).

    Article  Google Scholar 

  17. M. G. Sankalia, R. C. Mashru, R. C. Sankaliax, V. B. Sutariya. Papain Entrapment in alginate beads for stability improvement and site-specific delivery: Physicochemical characterization and factorial optimization using neural network modeling. AAPS PharmSciTech 6(2): article 31 (2005). http://www.aapspharmscitech.org.

  18. C. M. Lehr, J. A. Bowstra, J. J. Tukker, and H. E. Junginger. Intestinal transit of bioadhesive microspheres in an in situ loop in the rat. J Control Release. 13:51–62 (1990).

    Article  CAS  Google Scholar 

  19. H. M. Mukhtar, S. H. Ansari, M. Ali, Z. A. Bhat, and T. Naved. Effect of aqueous extract of Cyamopsis tetragonoloba Linn. beans on blood glucose level in normal and alloxan-induced diabetic rats. Indian J Exp Biol. 42:1212–1215 (2004).

    Google Scholar 

  20. S. Satyanarayana, and E. K. Kilari. Influence of nicorandil on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits. Mol Cell Biochem. 291:101–105 (2006).

    Article  CAS  Google Scholar 

  21. S. H. Yoo, Y. B. Song, P. S. Chang, and H. G. Lee. Microencapsulation of α tocopherol using sodium alginate and its controlled release properties. Int J Biol Macro. 38:25–30 (2006).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutics, Institute of Pharmacy, Bundelkhand University, Jhansi, Uttar Pradesh, India

    S. K. Prajapati & Purnima Tripathi

  2. Research and Development, Reddy’s Laboratory, Hyderabad, Andhra Pradesh, India

    Udhumansha Ubaidulla

  3. Department of Pharmaceutics, Seth G.L. Bihani S.D. College of Technical Education, Sri Ganganagar, Rajasthan, India

    Vikas Anand

Authors
  1. S. K. Prajapati
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Purnima Tripathi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Udhumansha Ubaidulla
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vikas Anand
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vikas Anand.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prajapati, S., Tripathi, P., Ubaidulla, U. et al. Design and Development of Gliclazide Mucoadhesive Microcapsules: In Vitro and In Vivo Evaluation. AAPS PharmSciTech 9, 224–230 (2008). https://doi.org/10.1208/s12249-008-9041-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-008-9041-0

Key words

Search

Navigation